Brief: CytoTools Signs Collaboration Agreement To Develop Inhalation Therapy For Viral Infections Such As COVID-19, Influenza
April 26 (Reuters) - CYTOTOOLS AG T5OG.DE :
* CYTOTOOLS SIGNS COLLABORATION AGREEMENT TO DEVELOP
INHALATION
THERAPY FOR VIRAL INFECTIONS SUCH AS COVID-19 AND INFLUENZA
* COMPLETION OF FURTHER DEVELOPMENT STEPS PLANNED BY END OF
Q3
* UNTIL COMPLETION OF CLINICAL PROOF-OF-CONCEPT, PROJECT
PLANNING
ASSUMES COSTS OF AROUND EUR 0.8 MILLION
Source text for Eikon: ID:nEQ2rlQLka
Further company coverage: T5OG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on bioXXmed AG
See all newsBrief: CytoTools Announces Completion Of Capital Increase
Brief: CytoTools - Disputes Between CytoTools, DermaTools, Shareholders Ended
Brief: CytoTools Announces Retirement Of Two Members Of Management Board
Brief: CytoTools Sees Complete Change Of Management Board And Supervisory Board Possible
Lordstown Motors says hedge fund may buy up to $400 mln of its stock (updated)